514
Views
0
CrossRef citations to date
0
Altmetric
Methods

The Clinical Toxicology Recommendations Collaborative: purpose, organization, and methodology

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 76-81 | Received 18 Jun 2023, Accepted 14 Feb 2024, Published online: 11 Mar 2024

References

  • Lavergne V, Nolin TD, Hoffman RS, et al. The EXTRIP (EXtracorporeal TReatments in poisoning) workgroup: guideline methodology. Clin Toxicol. 2012;50(5):403–413. doi:10.3109/15563650.2012.683436.
  • Institute of Medicine (U.S.). Committee on standards for developing trustworthy clinical practice guidelines., graham R. Clinical practice guidelines we can trust. Washington, DC: National Academies Press; 2011.
  • Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–842. doi:10.1503/cmaj.090449.
  • Gosselin S, Morris M, Miller-Nesbitt A, et al. Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol. 2015;53(6):557–564. doi:10.3109/15563650.2015.1052498.
  • Hoegberg LC, Bania TC, Lavergne V, et al. Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity. Clin Toxicol. 2016;54(3):167–193. doi:10.3109/15563650.2015.1121270.
  • Levine M, Hoffman RS, Lavergne V, et al. Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol. 2016;54(3):194–221. doi:10.3109/15563650.2015.1126286.
  • Hayes BD, Gosselin S, Calello DP, et al. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol. 2016;54(5):365–404. doi:10.3109/15563650.2016.1151528.
  • Grunbaum AM, Gilfix BM, Hoffman RS, et al. Review of the effect of intravenous lipid emulsion on laboratory analyses. Clin Toxicol. 2016;54(2):92–102. doi:10.3109/15563650.2015.1115515.
  • Gosselin S, Hoegberg LC, Hoffman RS, et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol. 2016;54(10):899–923. doi:10.1080/15563650.2016.1214275.
  • Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400. doi:10.1016/j.jclinepi.2010.09.012.
  • Covvey JR, McClendon C, Gionfriddo MR. Back to the basics: guidance for formulating good research questions. Res Social Adm Pharm. 2024;20(1):66–69. doi:10.1016/j.sapharm.2023.09.009.
  • Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407–415. doi:10.1016/j.jclinepi.2010.07.017.
  • Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA: RAND Corporation; 2001.
  • Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66(7):719–725. doi:10.1016/j.jclinepi.2012.03.013.
  • Guyatt GH, Alonso-Coello P, Schunemann HJ, et al. Guideline panels should seldom make good practice statements: guidance from the GRADE working group. J Clin Epidemiol. 2016;80:3–7. doi:10.1016/j.jclinepi.2016.07.006.
  • Venkatesh AK, Savage D, Sandefur B, et al. Systematic review of emergency medicine clinical practice guidelines: implications for research and policy. PLoS One. 2017;12(6):e0178456. doi:10.1371/journal.pone.0178456.
  • Vermeulen N, Le Clef N, Veleva Z, et al. European recommendations for good practice in addition to an evidence-based guidelines programme: rationale and method of development. BMJ Evid Based Med. 2019;24(1):30–34. doi:10.1136/bmjebm-2018-111032.
  • Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American heart association/American stroke association. Stroke. 2023;54(7):e314–e370. doi:10.1161/STR.0000000000000436.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.